KB
Korro Bio, Inc.
🇺🇸XNAS.KRROUnited StatesHealthcare
$13.97USDdown -0.13 (-0.92%)OpenDelayed5:39 PM
Price$13.97-0.13 (-0.92%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US5009461089
- CUSIP
- 500946108
Company
- Employees
- 57
- Headquarters
- Cambridge, United States
- Website
- https://www.korrobio.com
- CEO
- Dr. Ram Aiyar MBA, Ph.D.
Market
- Shares outstanding
- 14.7M
- Market cap
- $205.72M
Highlights
- Market cap
- $207.63M
- EPS LTM
- -$6.05
- P/E LTM
- -2.11
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $2.38M-62.08%down year on year
- Net income
- -$106.64M-16.74%down year on year
- Gross margin
- 56.8%-48.02%down year on year
- Free cash flow
- -$68.27M+7.57%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.